A Clinical Trial of an Herbal Liquid Supplement - 'DBPS' for Managing Blood Pressure

Prehypertension is a clinical condition characterized by systolic blood pressure (SBP) readings between 120 and 139 mmHg and/or diastolic blood pressure (DBP) readings between 80 and 89 mmHg, as per the Joint National Committee (JNC 7) and World Health Organization (WHO) guidelines. Individuals falling within this range do not yet meet the criteria for hypertension but are at a significantly elevated risk of progressing to full-blown hypertension and developing associated cardiovascular diseases such as heart attack and stroke. This stage is considered as a critical window for intervention, as timely and appropriate measures can potentially halt or delay the progression to more severe health issues.

NCT Number	NCT07629570
Lead Sponsor	Eetho Brands, Inc
Conditions	Prehypertension
Enrollment	198 participants
Start Date	2026-05-15
Primary Completion	2026-07-30 (estimated)
Study Completion	2026-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-05